The literature article entitled, "prevalence of subclinical cardiac abnormalities in patients with metal - on- metal hip replacements" written by f.Lodge, r.Khatun, r.Lord, a.John, a.G.Fraser, and z.Youse published by international journal of cardiology made available online 17 may 2018 was reviewed.The article's purpose: "we therefore performed a cross-sectional study of orthopaedic patients who had received mom hip prostheses to: a) ascertain the prevalence of overt cardiomyopathy and b) evaluate any relationship between subclinical markers of cardiac dysfunction and levels of plasma cobalt and chromium." data set was compiled from 95 mom hip patients and 15 controls with non mom hip prostheses.It is noted that depuy products are listed with non-depuy products utilized for mom prostheses.Article reports 18 patients had undergone prosthesis removal with average of 611 days post implantation.Article reports increased plasma cobalt level was associated with increasing heart size but "subjects had no evidence of myocardial dysfunctions in regards to the cardiac aspect of the study.It is noted that patients had elevated cobalt (co) and chromium (cr) levels.The article associates elevated ion levels to the metal on metal bearing surfaces articulation releasing metal related particles.The article does not provide clarification on which specific products are associated with specific adverse events.Depuy products: corail stem, pinnacle cup, metal liner, metal head.Adverse events: removal of prosthesis.Elevated ion levels.
|
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.A worldwide lot specific complaint database search, or device history record (dhr) review was not possible because the required lot code(s) was not provided.Based on previous investigations this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Corrective action was not indicated.
|